Regarding the vaccination schedule, we previously found in rat HER2/neu-transgenic mice that a fast, high induction of anti-HER2/neu antibodies was required to obtain the highest cancer immunopreventive activity [23,26]. The gene discussed is ERBB2; the disease is cancer.